Mouse Alpha Synuclein (SNCA) Protein (Active)

Product Graph
728€ (100 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Mouse Alpha Synuclein (SNCA) Protein (Active)
category
Proteins and Peptides
provider
Abbexa
reference
abx675049
tested applications
WB, SDS-PAGE

Description

Alpha Synuclein Protein (Active) is a recombinant Mouse protein expressed in E. coli.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Alpha Synuclein (SNCA)
Host
E. coli
Origin
Mouse
Observed MW
Molecular Weight: 14.46 kDa

Sequence Fragment: Full Length
Expression
Recombinant
Purity
> 95%
Purification
Ion-exchange Purified
Size 1
100 µg
Tested Applications
WB, SDS-PAGE
Buffer
PBS pH 7.4.
Availability
Shipped within 5-12 working days.
Storage
Store at -80°C.
Dry Ice
Yes
UniProt ID
O55042
Gene ID
20617
NCBI Accession
NP_001035916.1
Alias
SNCA
Background
Protein SNCA
Status
RUO
Note
This product is for research use only. This product is shipped with dry ice.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

Related Products

EH0582

Human SNCA (Alpha-synuclein) ELISA Kit

Ver Producto
FNab00345

SNCA antibody

Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene.

Ver Producto
FNab09891

SNCA antibody

Alpha-synuclein is a member of the synuclein family, which also includes beta- and gamma-synuclein. Synucleins are abundantly expressed in the brain and alpha- and beta-synuclein inhibit phospholipase D2 selectively. SNCA may serve to integrate presynaptic signaling and membrane trafficking. Defects in SNCA have been implicated in the pathogenesis of Parkinson disease. SNCA peptides are a major component of amyloid plaques in the brains of patients with Alzheimer's disease. Alternatively spliced transcripts encoding different isoforms have been identified for this gene.

Ver Producto